glutathione iv for parkinson's Enhanced accumulation of reduced by Scopoletin improves survivability of dopaminergic neurons in model Parkinson's disease and glutathione |
Description
Another major benefit of inhaled drug administration is its potential suitability for low-resource settings, in which simpler delivery methods and reduced need for medical infrastructure can be especially valuable
Thereby, this pitfall (i.e., the more carriers, the less own peptide activity) is commonly not considered (Saghazadeh et al., 2018
EGCG-NPs can be regarded as a new pharmacological agent because it restores necroptosis by inhibiting oxidative stress and inflammation
Gullner et al., 2001)
